Fazirsiran for Adults with Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)

By sjmartinez • July 5, 2024

Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Fazirsiran for Adults with Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. 2024 Jul 2:S0016-5085(24)05181-3. doi: 10.1053/j.gastro.2024.06.028. Epub ahead of print. PMID: 38964420.

Tags: AAT, alpha-1 antitrypsin deficiency, Fazirsiran, Liver disease, Publications, Pulmonary, Critical Care & Sleep Medicine, Z-AAT

Related Posts

Coronary Inflammation Is Associated With Plaque Progression in Men With HIV

Nasrallah N, Atallah M, Lattouf C, Harb T, Gerstenblith G, Haberlen S, Kelesidis T, Magnani JW, Stosor V, Chan K, Shirodaria C, Brown TT, Hays[...]

Sexual function after prostate cancer surgery or radiotherapy in an international registry

Hess-Busch Y, Darr C, Püllen L, Al-Nader M, Wahl M, Bailey AV, Wilhalme H, Lee J, Hadaschik B, Hess J; TrueNTH Global Registry. Sexual function[...]

Pulmonary Primary Oxysterol and Bile Acid Synthesis as a Predictor of Outcomes in Pulmonary Arterial Hypertension

Alotaibi M, Harvey LD, Nichols WC, Hemnes A, Sun W, Begzati A, Long T, Havulinna AS, Niiranen TJ, Desai AA, Cheng S, Jain M, Chan[...]